Department of Radiology

Publications

2024

Abdel-Rahman SA, Santini BL, Calvo-Barreiro L, Zacharias M, Gabr M. Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction. Bioorg Med Chem Lett. 2024:129599.

Mosconi L, Williams S, Carlton C, Zarate C, Boneu C, Fauci F, et al. Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's risk. Sci Rep. 2024;14(1):5519.

Ivanidze J, Chang SJ, Haghdel A, Kim JT, RoyChoudhury A, Wu A, et al. [Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas. Neuro Oncol. 2024.

2023

Abdel-Rahman SA, Rehman AU, Gabr MT. Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3). ACS Med Chem Lett. 2023;14(5):629-635.

Osborne JR. Randomized Trial of Five or Two MRI-guided Adaptive Radiotherapy Treatments for Prostate Cancer (FORT).. 2023.

Hope TA, Antonarakis ES, Bodei L, Calais J, Iravani A, Jacene H, et al. SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy. J Nucl Med. 2023;64(9):1417-1423.

Stangl-Kremser J, Ricaurte-Fajardo A, Subramanian K, Osborne JR, Sun M, Tagawa ST, et al. Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature. Prostate. 2023;83(10):901-911.

De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa AP, et al. Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma. Cancer Lett. 2023;570:216329.

Mauguen A, Grewal RK, Augensen F, Abusamra M, Mahajan S, Jayaprakasam VS, et al. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients. Eur J Nucl Med Mol Imaging. 2023;50(10):2971-2983.

Abdel-Rahman SA, Świderek K, Gabr MT. First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators. RSC Med Chem. 2023;14(9):1767-1777.